Predxbio

PredxBio is an AI-driven, tissue-based biomarker company, using spatial analytics and AI to turn tumor biopsy images into predictive biomarkers that improve oncology drug discovery, translational research, and clinical development. By integrating deep spatial analytics, microdomain biology, and tissue-based multi-omics, PredxBio delivers actionable biomarker insights that help pharmaceutical partners reveal mechanisms of response and resistance and guide biomarker-driven clinical trial design. PredxBio's end-to-end platform supports tissue QC, advanced spatial analysis, biomarker discovery, and translational deployment, making complex tumor biology accessible, interpretable, and ready for real-world clinical impact. info@predxbio.com